Destiny Wealth Partners, LLC Ligand Pharmaceuticals Inc Transaction History

Destiny Wealth Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 20, 2022	SELL	$127.69 - $165.85 $1,149 - $1,492	-9 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$102.33 - $144.73 $920 - $1,302	9 New	9 $1,000
Q2 2021 Jul 27, 2021	SELL	$113.03 - $155.64 $1,017 - $1,400	-9 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$80.55 - $106.05 $724 - $954	9 New	9 $1,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.89B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Destiny Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Destiny Wealth Partners, LLC with notifications on news.